Performance evaluation of MR-proadrenomedullin and other scoring systems in severe sepsis with pneumonia

• Published in: Journal of thoracic disease Vol. 6; no. 7; pp. 921 - 929
• Main Authors: Akpinar, Serdar, Rollas, Kazım, Alagöz, Ali, Seğmen, Fatih, Sipit, Tuğrul
• Format: Journal Article
• Language: English
• Published: China Pioneer Bioscience Publishing Company 01.07.2014
• Subjects: Original; pneumonia severity index (PSI); Proadrenomedullin (proADM); pneumonia; scoring systems; sepsis
• ISSN: 2072-1439; 2077-6624
• DOI: 10.3978/j.issn.2072-1439.2014.06.42

In sepsis, risk assessment is as crucial as early and accurate diagnosis. In this study, we aimed to evaluate the prognostic value of mid-regional proadrenomedullin (MR-proADM) with other scoring systems in severe sepsis and septic shock patients due to community acquired pneumonia (CAP). Patients were divided into 2 groups as severe sepsis and septic shock due to CAP (group 1, n=31) and only CAP group (group 2, n=26). Serum MR-proADM, procalcitonin (PCT), C-reactive protein (CRP), and d-dimer level were analyzed. Acute Physiological and Chronic Health Evaluation (APACHE) II score, Sequential Organ Failure Assessment (SOFA) score, and Pneumonia Severity Index (PSI) were performed for all patients. There was no difference between groups in terms of serum MR-proADM levels (P=0.780). Serum MR-proADM was not found a significant value for the prediction of death within the 4 and 8 weeks in all patients. SOFA score was the most significant to predict mortality in 4 and 8 weeks (P<0.001). The combination of SOFA score and serum MR-proADM was a strong factor to predict death in 4 weeks (specifity 86.8% and sensitivity 66.7%). The combination of MR-proADM, SOFA score, and APACHE II score was found 75.0% sensitive and 71.4% specific to predict mortality within 4 weeks in group 1. The MR-proADM does not correlate with mortality or disease severity to predict mortality. The combination of SOFA, APACHE II scores, and MR-proADM was efficient to predict prognosis and mortality rate in severe sepsis or septic shock patients.